Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

This early-phase trial tests the safety, dosing, and early effectiveness of a new drug called QXL138AM in people with advanced solid tumors (such as ovarian, lung, or pancreatic cancer) or multiple myeloma that has not responded to available treatments. **You may be eligible if...** - You have a confirmed advanced solid tumor (including ovarian, pancreatic, lung, kidney, liver, GI, prostate, or breast cancer) or multiple myeloma - Your cancer has progressed despite standard therapies, or no effective treatment exists for you - Your overall health and organ function meet the study requirements **You may NOT be eligible if...** - You have active brain metastases - You have had certain prior treatments that would overlap with this drug - You have serious heart problems or are pregnant Talk to your doctor to see if this trial is right for you.